Home > Insider Trading > Filing (0001127602-21-019273)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Bausch Health Companies Inc.	BHC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1681871	Christina Ackermann	400 Somerset Corporate Boulevard Bridgewater NJ 08807	Evp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares, No Par Value	Acquisiton	2021-06-02	60,345	$14.38	227,103	No	4	M	Direct
Common Shares, No Par Value	Acquisiton	2021-06-02	60,853	$15.32	287,956	No	4	M	Direct
Common Shares, No Par Value	Disposition	2021-06-02	121,198	$31.83	166,758	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares, No Par Value	Non-Qualified Stock Options (right to purchase)	Disposition	2021-06-02	60,345	$0.00	60,345	$14.38
Common Shares, No Par Value	Non-Qualified Stock Options (right to purchase)	Disposition	2021-06-02	60,853	$0.00	60,853	$15.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-03-01	No	4	M	Direct
0		2028-03-07	No	4	M	Direct

Footnotes

The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.61 to $32.11. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price.
The options vest in equal installments on each of the first three anniversaries of the date of grant.